Professional Seasonal Analysis for Trading

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

Seasonality Analysis

Stocks 8 Years Analyzed

Crinetics Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

14.76%
Avg Annual Return
56.3%
Avg Monthly Win Rate
6/12
Positive Months
8
Years Analyzed

Crinetics Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January WORST -7.46%
50%
Weak
February -1.83%
38%
Very Weak
March -6.60%
25%
Very Weak
April 7.70%
75%
Very Strong
May -2.68%
57%
Weak
June -1.50%
43%
Weak
July -3.32%
63%
Weak
August 6.44%
75%
Very Strong
September BEST 8.59%
25%
Weak
October 2.74%
63%
Strong
November 7.59%
88%
Very Strong
December 5.09%
75%
Very Strong

Crinetics Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
26.8
Historical Avg Position
32.65
Deviation
-5.85
Performance
Below Average

Crinetics Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for CRNX with overlay patterns, custom date ranges, and more.

Create Free Account

Crinetics Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Crinetics Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for CRNX across multiple timeframes.

Create Free Account

About Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) Seasonality

Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has been analyzed using 8 years of historical data to identify seasonal patterns. Classified under Stocks, Crinetics Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Crinetics Pharmaceuticals, Inc. - Common Stock is historically September, with an average return of 8.59% and a win rate of 25%. Conversely, January tends to be the weakest month, averaging -7.46% return.

Looking at the full calendar year, Crinetics Pharmaceuticals, Inc. - Common Stock has an average annual return of 14.76% with an overall monthly win rate of 56.3%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Crinetics Pharmaceuticals, Inc. - Common Stock has a consistency score of 47.5 (Poor), based on 9 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Crinetics Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)?

Historically, September has been the best month for Crinetics Pharmaceuticals, Inc. - Common Stock, with an average return of 8.59% and a win rate of 25%. However, past performance does not guarantee future results.

What is the worst month for Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)?

Based on historical data, January has been the weakest month for Crinetics Pharmaceuticals, Inc. - Common Stock, with an average return of -7.46%. This is a historical observation and does not guarantee future results.

How reliable is CRNX seasonality data?

The seasonality analysis for Crinetics Pharmaceuticals, Inc. - Common Stock is based on 8 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Crinetics Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.